日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammation

在一项针对肾移植受者同种异体移植炎症的前瞻性随机临床试验中,研究了体外扩增的多克隆调节性T细胞的药代动力学、谱系鉴定和迁移情况。

Chandran, Sindhu; Leung, Joey C; Vu, Alexander; Lee, Karim; Fitch, Mark; Esensten, Jonathan H; Shy, Brian R; Putnam, Amy L; Lares, Angela; Acevedo, Luis A; Nguyen, Vinh; Liu, Weihong; Armstrong, Brian; Laszik, Zoltan G; Mannon, Roslyn B; Friedewald, John J; Naik, Abhijit; Davis, Scott; Sarwal, Minnie; Hellerstein, Marc; Morsheimer, Megan; Goldstein, Julia; Tang, Qizhi; Vincenti, Flavio G

Selective Immune Silencing by Targeted TGF-β Agonists.

靶向TGF-β激动剂选择性免疫沉默。

Sun Qinli, Ogishi Masato, Jiang Hua, Barrett Alison K, Yan Hao, Sola Elsa, Zhang Jie, Xiao Peng, Lyu Huiyun, Salehi Ahmad, Tang Qizhi, Lanz Tobias V, Davis Mark M, Negrin Robert S, Garcia K Christopher

Transferrin receptor 1 nuclear translocation facilitates tumor progression via p53-mediated chromatin interactions and genome-wide alterations

转铁蛋白受体1核转位通过p53介导的染色质相互作用和全基因组改变促进肿瘤进展

Yaxin Hou # ,Guoheng Tang # ,Qizhi Wang ,Meng Zhou ,Ran Xu ,Xuehui Chen ,Guizhi Shi ,Zhuoran Wang ,Xiyun Yan ,Jie Zhuang ,Kelong Fan

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

利用细胞疗法治疗1型糖尿病:进展、挑战与未来展望

Grattoni, Alessandro; Korbutt, Gregory; Tomei, Alice A; García, Andrés J; Pepper, Andrew R; Stabler, Cherie; Brehm, Michael; Papas, Klearchos; Citro, Antonio; Shirwan, Haval; Millman, Jeffrey R; Melero-Martin, Juan; Graham, Melanie; Sefton, Michael; Ma, Minglin; Kenyon, Norma; Veiseh, Omid; Desai, Tejal A; Nostro, M Cristina; Marinac, Marjana; Sykes, Megan; Russ, Holger A; Odorico, Jon; Tang, Qizhi; Ricordi, Camillo; Latres, Esther; Mamrak, Nicholas E; Giraldo, Jaime; Poznansky, Mark C; de Vos, Paul

Rebalancing the Immune System to Treat Type 1 Diabetes

重新平衡免疫系统以治疗1型糖尿病

Muller, Yannick D; Ho, Patrick; Bluestone, Jeffrey A; Tang, Qizhi

Advances in Cell Replacement Therapies for Diabetes

糖尿病细胞替代疗法的进展

Hering, Bernhard J; Rickels, Michael R; Bellin, Melena D; Millman, Jeffrey R; Tomei, Alice A; García, Andrés J; Shirwan, Haval; Stabler, Cherie L; Ma, Minglin; Yi, Peng; Luo, Xunrong; Tang, Qizhi; Ramachandran, Sabarinathan; Oberholzer, Jose; Ricordi, Camillo; Kieffer, Timothy J; Shapiro, A M James

Regulatory T cell therapy for xenotransplantation, what perspectives?

异种移植中调节性T细胞疗法的前景如何?

Porret, Raphaël; Lana, Erica; Mancarella, Antonio; Guillaume, Philippe; Pascual, Manuel; Meier, Raphael P H; Bromberg, Jonathan S; Mohiuddin, Muhammad M; Buhler, Leo H; Tang, Qizhi; Muller, Yannick D

Programmable microparticles rewire CAR signaling to enable super-physiological expansion of human T cells in vitro

可编程微粒重塑CAR信号通路,从而在体外实现人T细胞的超生理扩增

Zeng, Qinghe; Flemming, Landon; Chen, Yuanzhou; Mazumder, Thomas; Hammerlindl, Heinz; Allen, Greg M; Almeida, Ricardo; Williams, Jasper Z; Hernández-López, Rogelio A; Eyquem, Justin; Ye, Chun J; Lim, Wendell A; Tang, Qizhi; Desai, Tejal A; Huang, Xiao

Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy

受体锚定的正交IL-2增强调节性T细胞疗法

Indart, Alyssa; Lyu, Huiyun; Nguyen, Vinh Q; Rosenthal, Wendy; Jang, Sophie S; Chen, Yue; Jude, Kevin; Su, Leon; Garcia, K Christopher; Bluestone, Jeffrey A; Tang, Qizhi

Ex Vivo Expanded Regulatory T Cells Inhibit AAA Progression by Limiting CD4+ and CD8+ T Cell Accumulation in Aortic Tissue

体外扩增的调节性T细胞通过限制主动脉组织中CD4+和CD8+ T细胞的积累来抑制腹主动脉瘤的进展。

Dasari, Chandrashekhar; Lopez, Jose Luis; Jan, Masood Shawyan; Shaligram, Sonali; Lin, Pei-Yu; Lévy-Lambert, Dina; Huang, April Gu; Valenzuela, Carlos Lizama; Hadley, Pierce; Tang, Qizhi; Oskowitz, Adam